Table 1.
Inclusion criteria | Exclusion criteria |
---|---|
Inpatients and ER patients aged >18 years | Arterial hypotension requiring inotropes or vasopressors (systolic blood pressure < 90 mmHg and mean arterial pressure < 70 mmHg) |
Anuria or bilateral urinary outlet obstruction | |
Uncontrolled diabetes mellitus (HbA1C > 9%) or glucose of >500 mg/dL at baseline or uncontrolled diabetic ketoacidosis or uncontrolled hyperosmolar hyperglycemic syndrome | |
Decompensated LC: known LC with ascites or diuretics use or hepatic encephalopathy or varix | |
Severe hypernatremia: glucose-corrected serum sodiuma ≥ 155 mmol/L | End-stage renal disease and receiving renal replacement therapy |
Patients who are pregnant or breastfeeding | |
If the following features occur within 30 days prior to randomization | |
History of cardiac surgery excluding PCA, acute myocardial infarction, sustained ventricular tachycardia, ventricular fibrillation, acute coronary syndrome, and admission for heart failure | |
Uncontrolled increase of intracranial pressure | |
Written consent | Subjects judged by investigators to have difficulty continuing the trial will also be excluded |
ER, emergency room; HbA1c, glycosylated hemoglobin; LC, liver cirrhosis; PCA, percutaneous coronary angioplasty.
Glucose-corrected serum (Na+) = measured (Na+) + 2.4 × (glucose [mg/dL] – 100 [mg/dL])/100 mg/dL